Related Experiment Video
Updated: Jul 16, 2026

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
Published on: May 21, 2021
Neutrophil elastase and cancer
Takashi Sato1, Satoshi Takahashi, Takao Mizumoto
1Department of Otolaryngology, Aichi-Gakuin University, Suemori-dori 2-11, Chikusa-ku 464-8651, Aichi, Japan.
Abstract:
This mini-review summarizes our recent experimental and clinical studies on neutrophil elastase (NE) and cancer based on our original view point. Neoplasms metastasize as a result of a complex series of events. This process requires various degradative enzymes including proteases. NE has broad substrate specificity under physiological conditions, and excessive NE results in digestion of not only elastin, but also other extracellular matrix proteins. Several cell lines from human breast cancer and human lung cancer produce immunoreactive NE. The amount of immunoreactive NE in tumor tissue is an independent prognostic indicator of patients with breast cancer and lung cancer. Furthermore, a specific NE inhibitor completely suppressed growth of cancer cells transplanted into severe combined immunodeficiency mice. The use of NE inhibitor would seem to be a promising way to prevent the invasion and metastasis of cancer.
Insights
Neutrophil elastase (NE) aids cancer metastasis by degrading extracellular matrix proteins. Inhibiting NE shows promise in preventing cancer invasion and spread.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Cancer metastasis involves complex proteolytic events.
- Neutrophil elastase (NE) is a protease with broad substrate specificity.
- Elevated NE levels are linked to cancer progression.
Purpose of the Study:
- To review experimental and clinical evidence on neutrophil elastase (NE) in cancer.
- To investigate the role of NE in tumor growth and metastasis.
- To evaluate the therapeutic potential of NE inhibitors in cancer treatment.
Main Methods:
- Analysis of experimental and clinical studies on NE and cancer.
- Assessment of NE expression in human breast and lung cancer cell lines and tissues.
- Evaluation of NE inhibitor efficacy in preclinical mouse models of cancer.
Main Results:
- Human breast and lung cancer cell lines produce immunoreactive NE.
- Tumor tissue NE levels are independent prognostic indicators for breast and lung cancer patients.
- A specific NE inhibitor significantly suppressed the growth of transplanted cancer cells in mice.
Conclusions:
- Neutrophil elastase plays a significant role in cancer invasion and metastasis.
- NE levels in tumors can serve as a prognostic biomarker.
- NE inhibitors represent a promising therapeutic strategy for preventing cancer metastasis.
More Related Videos
07:37Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics
Published on: June 7, 2018
08:59Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment
Published on: August 3, 2018
Related Concept Videos
Cancer Cell Migration through Invadopodia
Role of Matrix Metalloproteases in Degradation of ECM
A...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Selectins
DNA Helicases